Bioventus

Durham, United States

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely.

$400.0M raised

Jul 2025

Post-IPO Debt

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Bioventus raised?

Bioventus has raised $400.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in July 2025.

Who are Bioventus's investors?

Bioventus's investors include Wells Fargo, Ampersand Capital Partners, Alcentra Capital Corporation.

Where is Bioventus headquartered?

Bioventus is headquartered in Durham, United States.

What does Bioventus do?

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely.

What stage is Bioventus at?

Bioventus is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 31, 2025.

MLA

"Bioventus — Funding & Investors." VCBacked, July 31, 2025, https://www.vcbacked.co/company/bioventus. Accessed July 2, 2026.

APA

VCBacked. (2025). Bioventus — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bioventus

Wikipedia (cite web)

{{cite web |title=Bioventus — Funding & Investors |url=https://www.vcbacked.co/company/bioventus |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 31, 2025.